Early Doppler studies in lupus pregnancy.

Area of Science:

• Obstetrics and Gynecology
• Rheumatology
• Maternal-Fetal Medicine

Background:

• Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) pose significant risks to pregnancy.
• Effective monitoring and prediction of pregnancy complications in these patients are crucial for maternal and fetal well-being.

Purpose of the Study:

• To evaluate the utility of serial Doppler blood flow studies in predicting pregnancy outcomes.
• To compare the predictive accuracy of end-diastolic blood flow (EDF), anticardiolipin antibodies (aCL), and lupus anticoagulant (LAC) for pregnancy complications.

Main Methods:

• Prospective study of 56 pregnancies in 54 patients with SLE or APS.
• Serial Doppler ultrasonography of umbilical and uterine arteries from 14 weeks' gestation.
• Correlation of EDF, aCL, and LAC with pregnancy outcomes: mortality, Cesarean delivery, hypertension, and gestational age.

Main Results:

• Absence of end-diastolic blood flow (EDF) was a strong predictor of Cesarean delivery.
• Presence of EDF and absence of aCL correlated with normotensive pregnancies.
• Lupus anticoagulant (LAC) demonstrated the highest accuracy in predicting fetal demise.

Conclusions:

• Doppler end-diastolic blood flow (EDF) is a valuable tool for predicting pregnancy outcomes in high-risk patients.
• Combining Doppler studies with serological markers like LAC can improve the prediction of adverse pregnancy events in SLE and APS.
• Intensive fetal and maternal monitoring, guided by these predictive markers, optimizes delivery timing and management.